To study the Ayurvedic management of Diabetes Mellitus

"Randomised Control Trial on Virechana Followed by Daruharidradi Ghanavati in Sthula Madhumeha with reference to Type 2 Diabetes Mellitus"

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/030896

Enrollment

Registered

2021-02-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Virechana followed by Daruharidradi Ghanavati: Rukshana Pachana Kwatha 20ml BD will be given to Sthula-Madhumehi patient for 5 days then Snehapan by Panchatikta Ghritpana as 30ml, 45ml,

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients who are willing to participate in trial(Virechana) and ready to give written consent. 2)patients having complaints regarding Sthula Madhumeha mentioned in Ayurvedic Classics and fulfilling criteria of diagnosis more than 50%. 3)patients who have not participated in any research project in last 6 months. 4) Newly detected and Known case of DM type 2 having FBS more than 125mg/dl and PMS more than 200mg/dl. 5)patient having BMI in between 23 to 35 will be selected. 6) patients with controlled Hypertension in the range of 120/80 mm of Hg to 140/90 mm of Hg. 7)HbA1c ranging from 6.5% to 9%. 8) selection of patients will be done irrespective of sex,socioeconomically status and religion.

Exclusion criteria

Exclusion criteria: 1)Patients who are not willing to participate in trial(Virechana) and not ready to give written consent. 2)patients having age below 30 and above 70 years. 3)patients having both of fasting blood sugar level more than 225mg/dl and post meal blood sugar level more than 350mg/dl. 4)patients having BMI less than 23 and above 35. 5) pregnant women and lactating mothers. 6)patients having Insulin Dependent Diabetes Mellitus. 7)patients having complications like vasculopathy, nephropathy, retinopathy or neuropathy. 8)patients with uncontrolled Hypertension i.e. more than 150/100 mm of Hg. 9) patients having other systemic complications.

Design outcomes

Primary

Measure	Time frame
Virechana followed by Daruharidradi Ghanavati will be as effective as Daruharidradi Ghanavati only on B.S.L and B.M.I. in Sthula Madhumeha w.r.t. Type 2 DM.Timepoint: 35 days	—

Secondary

Measure	Time frame
To evaluate the effect of Virechana followed by Daruharidradi Ghanavati on B.S.L. and B.M.I. and to compare its result with that of Daruharidradi Ghanavati only.Timepoint: 35 days	—

Countries

India

Contacts

Public ContactDr Ashish Thatere

Government Ayurved College and Hospital, Nagpur

ashish.thatere@gmail.com9423406821

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026